share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer JOHNSON RADY A

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer JOHNSON RADY A

輝瑞 | 4:持股變動聲明-高管 JOHNSON RADY A
美股sec公告 ·  08/02 11:39
Moomoo AI 已提取核心訊息
Pfizer Inc. (PFE) Executive Vice President Rady A. Johnson engaged in a transaction involving the company's stock on July 31, 2024. The specific details of the transaction, such as the number of shares traded, the nature of the shares, the transaction price, and the total value of the shares, were not disclosed in the announcement. The action type and status of the transaction were also not provided. Investors are advised to seek additional information to fully understand the impact of this event on their investment decisions.
Pfizer Inc. (PFE) Executive Vice President Rady A. Johnson engaged in a transaction involving the company's stock on July 31, 2024. The specific details of the transaction, such as the number of shares traded, the nature of the shares, the transaction price, and the total value of the shares, were not disclosed in the announcement. The action type and status of the transaction were also not provided. Investors are advised to seek additional information to fully understand the impact of this event on their investment decisions.
2024年7月31日,輝瑞製藥公司(PFE)執行副總裁Rady A. Johnson涉及了該公司的股票交易。公告中未披露交易的具體細節,如交易的股份數量、股份的性質、交易價格及股份的總價值。同時,該交易的動作類型和狀態也未知。建議投資者尋求額外信息以充分了解該事件對其投資決策的影響。
2024年7月31日,輝瑞製藥公司(PFE)執行副總裁Rady A. Johnson涉及了該公司的股票交易。公告中未披露交易的具體細節,如交易的股份數量、股份的性質、交易價格及股份的總價值。同時,該交易的動作類型和狀態也未知。建議投資者尋求額外信息以充分了解該事件對其投資決策的影響。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息